Breaking News Instant updates and real-time market news.

SCPH

scPharmaceuticals

$5.93

(0.00%)

09:49
06/14/18
06/14
09:49
06/14/18
09:49

scPharmaceuticals price target lowered to $12 from $20 at Leerink

Leerink analyst Ami Fadia lowered her price target for scPharmaceuticals to $12 from $20 after the company announced that it received a Complete Response Letter from the FDA on Furoscix. The analyst believes that making changes to the design of the device - should the FDA ultimately require it - is no small task and a resubmission involving this will likely take longer than her previous 6-12 month delay estimate to fully complete. In light of this uncertainty, Fadia pushes out approval of Furoscix by 2 years to mid-2020. The analyst reiterates an Outperform rating on the shares.

  • 23

    Jun

SCPH scPharmaceuticals
$5.93

(0.00%)

05/31/18
BMOC
05/31/18
NO CHANGE
Target $24
BMOC
Outperform
scPharmaceuticals likely to receive CRL for Furoscix, says BMO Capital
scPharmaceuticals is likely receive a Complete Response Letter and a delay to approval after the FDA identified deficiencies in the Furoscix new drug application, BMO Capital analyst Gary Nachman tells investors in a research note. After speaking to management, the analyst thinks scPharmaceuticals will work though the issues in time. He does not anticipate a major safety concern since furosemide is a well-known compound used for years in heart failure diuresis. Nachman says he'd be surprised if an additional clinical study is required. The analyst keeps an Outperform rating on scPharmaceuticals with a $24 price target. The stock in morning trading is down 31% to $9.78.
06/01/18
JEFF
06/01/18
NO CHANGE
Target $26
JEFF
Buy
scPharmaceuticals likely to receive CRL for Furoscix, says Jefferies
After the FDA found deficiencies in Furoscix's new drug application filing, Jefferies analyst David Steinberg sees increased likelihood that the company receives a complete response letter by the June 23 action date. This is likely to have a minimal financial Impact for this year, Steinberg tells investors in a research note. His model assumes a Q4 Furoscix launch, with "very modest" contributions from scPharmaceuticals' heart failure product candidate this year. The analyst keeps a Buy rating on scPharmaceuticals with a $26 price target.
06/13/18
BMOC
06/13/18
NO CHANGE
Target $14
BMOC
Outperform
scPharmaceuticals' Furoscix 'still alive' despite CRL, says BMO Capital
BMO Capital analyst Gary Nachman said scPharmaceuticals' announcement of a Complete Response Letter, or CRL, from the FDA regarding its application for Furoscix was "disappointing but expected." Nachman, who still believes there will be an ultimate path forward for Furoscix, is now assuming a one to two year delay and is lowering his estimates. He maintains an Outperform rating on the stock, but lowered his price target for scPharmaceuticals shares to $14 from $24.
06/14/18
JEFF
06/14/18
NO CHANGE
Target $12
JEFF
Buy
scPharmaceuticals price target lowered to $12 from $26 at Jefferies
Jefferies analyst David Steinberg lowered his price target for scPharmaceuticals to $12 after the company received a Complete Response Letter for its heart failure product candidate Furosci. The letter, which indicated the need for additional human factor studies, device modifications, and a possible clinical validation study, is "arguably more onerous than previously expected," Steinberg tells investors in a research note. The analyst, however, continues to view Furoscix as approvable and keeps a Buy rating on scPharmaceuticals.

TODAY'S FREE FLY STORIES

NKE

Nike

$84.51

0.24 (0.28%)

, UA

Under Armour

$18.49

-0.345 (-1.83%)

11:03
09/25/18
09/25
11:03
09/25/18
11:03
Earnings
Fly Intel: What to watch in Nike's earnings report »

Nike (NKE) is scheduled…

NKE

Nike

$84.51

0.24 (0.28%)

UA

Under Armour

$18.49

-0.345 (-1.83%)

UAA

Under Armour

$20.20

-0.5 (-2.42%)

ADDYY

Adidas

$0.00

(0.00%)

AMZN

Amazon.com

$1,948.00

13.5 (0.70%)

WMT

Walmart

$95.56

0.62 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 28

    Oct

  • 15

    Nov

  • 27

    Nov

  • 03

    Mar

TS

Tenaris

$34.78

1.795 (5.44%)

, ABX

Barrick Gold

$11.46

0.43 (3.90%)

11:00
09/25/18
09/25
11:00
09/25/18
11:00
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

TS

Tenaris

$34.78

1.795 (5.44%)

ABX

Barrick Gold

$11.46

0.43 (3.90%)

GOLD

Randgold

$71.67

3.55 (5.21%)

INTC

Intel

$46.05

-0.86 (-1.83%)

SIRI

Sirius XM

$6.25

-0.005 (-0.08%)

P

Pandora

$9.01

0.03 (0.33%)

CGC

Canopy Growth

$54.79

2.32 (4.42%)

STZ

Constellation Brands

$215.17

-1.14 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 04

    Oct

  • 13

    Oct

  • 22

    Oct

  • 28

    Oct

  • 13

    Nov

GE

General Electric

$11.53

-0.215 (-1.83%)

11:00
09/25/18
09/25
11:00
09/25/18
11:00
Options
50K GE Dec 16 - Jun 12 call spreads bought for 99c »

50K GE Dec 16 - Jun 12…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

VZ

Verizon

$53.42

-0.13 (-0.24%)

10:59
09/25/18
09/25
10:59
09/25/18
10:59
Periodicals
Verizon offers early-retirement packages to 'thousands' of staff, WSJ reports »

In a move to trim its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 12

    Nov

  • 13

    Nov

VIOT

Viomi Technology

$0.00

(0.00%)

10:54
09/25/18
09/25
10:54
09/25/18
10:54
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CNP

CenterPoint Energy

$27.24

-0.57 (-2.05%)

10:53
09/25/18
09/25
10:53
09/25/18
10:53
Conference/Events
CenterPoint Energy participates in a conference call with Morgan Stanley »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 26

    Sep

SONC

Sonic

$43.35

6.74 (18.41%)

10:52
09/25/18
09/25
10:52
09/25/18
10:52
Downgrade
Sonic rating change  »

Sonic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BMWYY

BMW

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:48
09/25/18
09/25
10:48
09/25/18
10:48
Hot Stocks
BMW cuts view due to 'unexpected intense' competition following new standards »

Shares of automakers were…

BMWYY

BMW

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

GM

General Motors

$34.24

-0.5 (-1.44%)

FCAU

Fiat Chrysler

$18.13

-0.18 (-0.98%)

F

Ford

$9.52

-0.065 (-0.68%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

BJ

BJ's Wholesale

$27.47

-1 (-3.51%)

10:48
09/25/18
09/25
10:48
09/25/18
10:48
Conference/Events
BJ's Wholesale participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Oct

  • 27

    Sep

VIOT

Viomi Technology

$0.00

(0.00%)

10:47
09/25/18
09/25
10:47
09/25/18
10:47
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PETQ

PetIQ

$39.45

-1.62 (-3.94%)

10:46
09/25/18
09/25
10:46
09/25/18
10:46
Conference/Events
PetIQ participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

CVX

Chevron

$123.58

0.92 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Options
Chevron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

ALDR

Alder Biopharmaceuticals

$16.88

0.125 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Conference/Events
Alder Biopharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TNDM

TNDM

10:42
09/25/18
09/25
10:42
09/25/18
10:42
Recommendations
TNDM analyst commentary  »

Baird not surprised by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Nov

10:40
09/25/18
09/25
10:40
09/25/18
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD popped…

TWTR

Twitter

$28.93

0.34 (1.19%)

10:39
09/25/18
09/25
10:39
09/25/18
10:39
Hot Stocks
Twitter releases new policy to ban dehumanizing speech »

In a blog post, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 07

    Nov

VIOT

Viomi Technology

$0.00

(0.00%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FCAU

Fiat Chrysler

$18.22

-0.09 (-0.49%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
09/25/18
09/25
10:35
09/25/18
10:35
General news
The U.S. consumer confidence »

The U.S. consumer…

CBM

Cambrex

$65.05

1.95 (3.09%)

10:31
09/25/18
09/25
10:31
09/25/18
10:31
Hot Stocks
Cambrex to expand, invest at High Point, North Carolina site »

Cambrex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VNTR

Venator Materials

$9.41

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Downgrade
Venator Materials rating change  »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
09/25/18
09/25
10:25
09/25/18
10:25
General news
U.S. Richmond Fed manufacturing index climbed 5 points to 29 in September »

U.S. Richmond Fed…

RHHBY

Roche

$0.00

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
Roche to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
UBS waste market/recycling analyst to hold an analyst/industry conference call »

Analyst Windham, along…

VIOT

Viomi Technology

$0.00

(0.00%)

10:21
09/25/18
09/25
10:21
09/25/18
10:21
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.